surmount studies tirzepatide SURMOUNT‐4 study design. This is a phase 3, multicenter, randomized, surmount-1 trial tirzepatide non-diabetic obesity

Retatrutide is sometimes described informally as a successor to Mounjaro because both were developed by Lilly and retatrutide adds a third receptor target

In 2025, the semaglutide Rybelsus was the first oral GLP-1 to receive the indication

Dr Amit Srivastava Weight Loss Specialist UK November 1, 2025 Dr Amit Srivastava Weight Loss Specialist UK 4 min read September 25, 2025 Dr Amit Srivastava Weight Loss Specialist UK 4 min read September 15, 2025 Dr Amit Srivastava Weight Loss Specialist UK 2 min read

Ferroptotic propagation: from single-cell execution to tissue-scale death programs

The benefits of GLP1 receptors in cardiovascular diseases

Biological Activity The LR3 IGF-I/IGF-1 protein is similar to insulin and has potent growth-promoting activity that exceeds the efficacy of insulin